questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NHS England’s criterion for eligibility for indication-specific pricing to demonstrate revenue loss on the UK’s international competitiveness in life sciences.
answerText: The Government is taking decisive steps to secure the future of life sciences research in the United Kingdom and to ensure we remain internationally competitive. The upcoming Life Sciences Sector Plan sets out a bold vision to strengthen our world-class r...
heading: Drugs: Prices